论文部分内容阅读
目的评价血栓通联合胞磷胆碱注射液治疗缺血性脑卒中的成本-效果。方法选取2013年5月至2015年2月收治的80例缺血性脑卒中住院患者作为研究对象,将其按随机数字表法分为两组,A组患者给予血栓通联合胞磷胆碱注射液;B组患者给予血栓通注射液。对两组患者的疗效及成本-效果进行分析。结果经治疗后,A组患者临床总有效率明显高于B组,差异有统计学意义(P<0.05);A组患者成本-效果比明显小于B组。结论血栓通联合胞磷胆碱钠注射液治疗缺血性脑卒中较单用血栓通注射液,其成本-效果具有明显的优势,可进一步扩大临床研究范围,规范该治疗方案。
Objective To evaluate the cost-effectiveness of Xueshuantong combined with citicoline injection in the treatment of ischemic stroke. Methods Totally 80 inpatients with ischemic stroke admitted to our hospital from May 2013 to February 2015 were selected and divided into two groups according to random number table. Patients in group A received thrombosis combined with citicoline injection Liquid; Group B patients given Xueshuantong injection. The efficacy and cost-effectiveness of the two groups were analyzed. Results After treatment, the total effective rate of group A was significantly higher than that of group B (P <0.05). The cost-effect ratio of group A was significantly lower than that of group B. Conclusion Xueshuantong combined with citicoline sodium injection in the treatment of ischemic stroke than the single Xueshuantong injection, the cost - effect has obvious advantages, can further expand the scope of clinical research, regulate the treatment.